Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: Insights from the BEACON CRC study
Tabernero, J., Velez, L., Trevino, T. L., Grothey, A., Yaeger, R., Van Cutsem, E., . . . Kopetz, S. (2021). … Read More